0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Current Clinical Issues |

Cancer Chemotherapy: Teaching Old Drugs New Tricks

Brigid Kane
[+] Article and Author Information

Copyright ©2004 by the American College of Physicians


Ann Intern Med. 2001;135(12):1107-1110. doi:10.7326/0003-4819-135-12-200112180-00035
Text Size: A A A

For most of the millions of patients with cancer (Table), the toxicity associated with cancer chemotherapy is frequently the rate-limiting factor in the use of potentially effective drugs. The indiscriminate cytotoxicity of cancer drugs—the killing of healthy and cancerous cells alike—means that it is often not possible to use what should be the best available single or combination chemotherapeutic agents. Other consequences of the toxicity of cancer chemotherapy include using a suboptimal dose or intermittent dosing schedules (alternating chemotherapy with rest periods) or forgoing chemotherapy altogether. The elderly and patients with comorbid illnesses are most likely to forgo or ask to discontinue chemotherapy, noted Gary Lyman, MD, MPH, director of the Cancer Center and a professor of medicine at Albany Medical College in New York.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Topic Collections
PubMed Articles
Therapy: This time it's personal. Nature 2014;509(7502):S52-4.
Engineered nanomedicine for myeloma and bone microenvironment targeting. Proc Natl Acad Sci U S A 2014;111(28):10287-92.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)